Open-label Extension for Phase 3 Clinical Trials of Simufilam

Clinical trial NCT05575076 · TERMINATED

Trial details

NCT number: NCT05575076
Sponsor: Cassava Sciences, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2022-11-07
Primary completion: 2025-01-31
Enrollment: 1081

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.